STOCK OPTIONS (Tables)

9 Months Ended

12 Months Ended

Dec. 31, 2018

Mar. 31, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Share-based Compensation, Performance Shares Award Outstanding Activity [Table Text Block]

The following is a summary of stock options outstanding and exercisable as of December 31, 2018:

Exercise Price ($)		Number of Options		Expiry Date	Exercisable Options
	34.50		630	June 20, 2021		630
	34.50		13,212	July 1, 2021		13,212
	34.50		944	February 17, 2022		944
	183.00		2,667	November 24, 2022		2,667
	150.00		12,289	December 14, 2022		12,289
	142.50		359	March 28, 2023		359
	157.50		1,387	March 28, 2023		1,387
	150.00		1,112	April 26, 2023		1,112
	105.00		2,667	February 6, 2024		889
	102.00		1,667	February 13, 2024		1,667
	142.50		106	March 3, 2024		106
	157.50		408	March 3, 2024		408
	142.50		43	March 14, 2024		43
	157.50		164	March 14,2024		164
	142.50		485	September 30, 2024		485
	157.50		1,876	September 30, 2024		1,876
	142.50		24	June 2, 2025		24
	157.50		90	June 2, 2025		90
	37.50		442	December 30, 2025		442
	142.50		328	December 30, 2025		328
	24.15		81,436	September 1, 2027		27,146
	23.25		17,600	January 24, 2025		-
	9.735		40,000	April 19, 2028		40,000
	6.93		5,000	June 10, 2025		-
			184,936			106,268

The following is a summary of stock options outstanding and exercisable as of March 31, 2018:

Exercise Price ($)	Number of Options		Expiry Date	Exercisable Options
24.75		1,762	April 1, 2021		1,762
34.50		651	June 20, 2021		651
34.50		13,212	July 1, 2021		13,212
34.50		944	February 17, 2022		944
183.00		2,667	November 24, 2022		1,778
150.00		13,289	December 14, 2022		11,178
142.50		747	March 28, 2023		747
157.50		2,887	March 28, 2023		2,887
150.00		1,667	April 26, 2023		556
150.00		5,000	August 8, 2023		1,667
105.00		2,667	February 6, 2024		889
102.00		1,667	February 13, 2024		1,111
142.50		211	March 3, 2024		211
157.50		816	March 3, 2024		816
142.50		43	March 14, 2024		43
157.50		164	March 14, 2024		164
142.50		485	September 30, 2024		485
157.50		1,876	September 30, 2024		1,876
142.50		23	June 2, 2025		23
157.50		90	June 2, 2025		90
37.50		442	December 30, 2025		442
142.50		328	December 30, 2025		182
31.50		13,334	August 3, 2024		-
24.15		81,436	September 1, 2027		13,573
23.25		24,267	January 24, 2025		-
		170,675			55,287

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

These options at their respective grant dates were valued using the Black-Scholes option pricing model with the following key assumptions:

	Expected life		Risk free			Dividend			Forfeiture			Expected			Grant date
Grant date	in years		rate			rate			rate			volatility			fair value
February 17, 2015		3.89		1.59	%		0	%		0	%		114	%	$	136,613
July 1, 2014		3.25		1.59	%		0	%		0	%		114	%	$	1,259,487
June 20, 2014		3.22		1.59	%		0	%		0	%		114	%	$	118,957
April 1, 2014		3.01		1.59	%		0	%		0	%		114	%	$	230,930
November 24, 2015		4.65		1.59	%		0	%		0	%		114	%	$	694,384
December 14, 2015		4.71		1.59	%		0	%		0	%		114	%	$	1,260,437
April 21, 2016		6.11		1.59	%		0	%		0	%		114	%	$	2,582,890
April 26, 2016		5.07		1.59	%		0	%		0	%		114	%	$	213,750
August 8, 2016		5.36		1.59	%		0	%		0	%		114	%	$	652,068
February 6, 2017		5.86		1.59	%		0	%		0	%		114	%	$	245,200
February 13, 2017		5.88		1.59	%		0	%		0	%		114	%	$	148,750
August 3, 2017		6.35		1.59	%		0	%		0	%		114	%	$	387,209
September 1, 2017		9.43		1.59	%		0	%		0	%		114	%		1,832,304
January 24, 2018		6.82		1.59	%		0	%		0	%		114	%	$	491,036

Share-based Compensation, Stock Options, Activity [Table Text Block]

				Weighted-Average
	Number of Options			Exercise Price ($)
Outstanding, March 31, 2017		66,024			88.50
Issued		119,036			23.25
Exercised		-			-
Expired		-			-
Cancelled		(14,385	)		97.50
Outstanding, March 31, 2018		170,675			75.00

Schedule of Share-based Payment Award,Reclassification of Stock Options, Valuation Assumptions [Table Text Block]

As the Company does not have sufficient authorized shares of common stock to cover its options issued, a valuation of these options was done at March 31, 2018 and the resulting liability of $1,451,393 has been recorded in the consolidated balance sheet as shares to be issued, stock options and warrants.

Grant Date	Expected Life		Risk Free rate			Dividend rate			Forfeiture Rate			Expected Volatility			Remeasured Fair Value
February 17, 2015		3.89		1.59	%		0	%		0	%		135	%	$	7,122
July 1, 2014		3.25		1.59	%		0	%		0	%		135	%	$	90,472
June 20, 2014		3.22		1.59	%		0	%		0	%		135	%	$	4,428
April 1, 2014		3.01		1.59	%		0	%		0	%		135	%	$	12,437
November 24, 2015		4.65		1.59	%		0	%		0	%		135	%	$	16,327
December 14, 2015		4.71		1.59	%		0	%		0	%		135	%	$	85,833
April 21, 2016		6.39		1.59	%		0	%		0	%		118	%	$	53,853
April 26, 2016		5.07		1.59	%		0	%		0	%		114	%	$	11,430
August 8, 2016		5.36		1.59	%		0	%		0	%		114	%	$	35,722
February 6, 2017		5.86		1.59	%		0	%		0	%		114	%	$	16,969
February 13, 2017		5.88		1.59	%		0	%		0	%		114	%	$	10,703
August 3, 2017		6.35		1.59	%		0	%		0	%		114	%	$	109,970
September 1, 2017		9.43		1.59	%		0	%		0	%		114	%	$	782,966
January 24, 2018		6.82		1.59	%		0	%		0	%		114	%	$	213,161
																1,451,393